BEIJING SL PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.61 CNY | +2.74% |
|
+3.61% | -15.51% |
| Apr. 24 | Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
| Apr. 23 | Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Beijing SL Pharmaceutical Co., Ltd. specializes in manufacturing and marketing medicines produced by genetic engineering. Products are primarily for treating neutropenia, thrombocytopenia, renal cancer, melanoma and chronic skin ulcer.
Sector
Pharmaceuticals
Calendar
2024-05-23
- Annual General Meeting
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
8.61
CNY
Average target price
12
CNY
Spread / Average Target
+39.37%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.51% | 1.22B | |
| +26.47% | 664B | |
| +26.74% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +13.43% | 234B | |
| +4.71% | 199B | |
| -9.53% | 196B | |
| -4.04% | 148B |
- Stock Market
- Equities
- 002038 Stock
- News Beijing SL Pharmaceutical Co., Ltd.
- Beijing SL Pharma Gets Registration Certificate for Cancer Drug
